Radiation Biodosimetry in Children Undergoing Total Body Irradiation
NCT01337648 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2
Last updated 2016-06-22
Summary
The purpose of this study is to develop fecal tests that will determine the extent of radiation exposure in patients undergoing radiation treatment for cancer. This project will determine whether fecal biomarkers can be used to diagnose exposure to radiation.
Conditions
- Total-body Irradiation
- Hematopoietic Stem Cell Transplant
Sponsors & Collaborators
-
Medical College of Wisconsin
lead OTHER
Principal Investigators
-
John Baker, MD · Medical College of Wisconsin
Eligibility
- Min Age
- 2 Years
- Max Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-11-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- United States
Study Locations
More Related Trials
-
Prospective Study on Factors Predicting Chemo-Radiotherapy Induced Pulmonary and Esophageal Injury
NCT00631839 ·Status: UNKNOWN
-
Flare Measurements in Human Radiation Therapy Patients
NCT01640236 ·Status: COMPLETED
-
Dynamic Perfusion Computed Tomography in Patients With Localized Non-small Cell Lung Cancer
NCT03091816 ·Status: COMPLETED
-
Stereotactic Radiosurgery in Treating Patients With Liver Metastases, Lung Metastases, or Other Advanced Solid Tumors
NCT00006456 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Lung Function After Radiation Therapy
NCT01039649 ·Status: COMPLETED
-
One Fraction Simulation-Free Treatment With CT-Guided Stereotactic Adaptive Radiotherapy for Patients With Oligometastatic and Primary Lung Tumors
NCT06236516 ·Status: COMPLETED ·Phase: NA
-
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
NCT00897793 ·Status: COMPLETED
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
NCT00471835 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Oligometastatic Renal Cell Carcinoma
NCT03575611 ·Status: SUSPENDED ·Phase: PHASE2
-
Cetuximab and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT00124618 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Volumetric Radiotherapy in Prostate Cancer
NCT02423889 ·Status: COMPLETED ·Phase: PHASE2
-
Optimising Molecular Radionuclide Therapy
NCT04922801 ·Status: COMPLETED
-
Phase 1/2 Study to Determine Optimal Dose for Treating Bone Metastases Using Novel STAT-RT Workflow
NCT02145286 ·Status: UNKNOWN ·Phase: NA
-
Detection of Circulating Biomarkers of Immunogenic Cell Death
NCT02921854 ·Status: COMPLETED ·Phase: NA
-
Radiation Induced Cardiopulmonary Injury in Humans
NCT02259452 ·Status: TERMINATED
-
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
NCT00026650 ·Status: RECRUITING
-
Radiotherapy Assessments During Intervention ANd Treatment (RADIANT)
NCT03133286 ·Status: COMPLETED
-
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC
NCT00246181 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Phase II Study of Stereotactic Body Radiation Therapy Using Tomotherapy for Tumors of the Lung
NCT00832780 ·Status: COMPLETED ·Phase: NA
-
Investigation of Circulating Tumor Cells From Cancer Patients Undergoing Radiation Therapy
NCT02449837 ·Status: COMPLETED
-
3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent Tumors
NCT01470365 ·Status: COMPLETED ·Phase: PHASE1
-
Retrospective Study of Radio-induced Toxicities in the Treatment of Lung Cancer With Tomotherapy
NCT05883735 ·Status: COMPLETED
-
PET/CT-Guided Biological Target Volume Delineation and Dose Optimization for Radioactive Seed Implantation Therapy in Malignant Tumors
NCT07327515 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
NCT03035890 ·Status: COMPLETED ·Phase: NA
-
Stereotactic Body Radiation Therapy and T-Cell Infusion in Treating Patients With Metastatic Kidney Cancer
NCT01943188 ·Status: TERMINATED ·Phase: PHASE1